Concurrent 7C: Interventions to Improve the HCV Care Cascade
Tracks
.
Friday, October 11, 2024 |
2:15 PM - 3:30 PM |
MC2 |
Speaker
Mr Mohammed Majam
Director of Medical Technologies
Ezintsha, University of Witwatersrand
HCV Self-Testing as a Gateway to Identification Among Key Populations with No Previous HCV Screening Experience in Johannesburg, South Africa
2:15 PM - 2:30 PMBiography
Mohammed Majam is the Director for Medical Technologies at Ezintsha, at Wits University in Johannesburg. He has been a leading role player in driving the agenda for self-testing forward both in South Africa and globally. He serves on various technical working groups for WHO, and the NDOH in SA. Mohammed lead the STAR programme in SA which oversaw the implementation programme for HIV self-screening in the country. Currently his work is focussing on Hep C and STI Self-testing.
Dr. Guillaume Fontaine
Assistant Professor
McGill University
EVALUATING THE IMPACT THEORY OF THE NATIONAL AUSTRALIAN HEPATITIS C POINT-OF-CARE TESTING PROGRAM: AN IMPLEMENTATION SCIENCE-INFORMED STUDY
2:30 PM - 2:45 PMBiography
Prof. Fontaine is an Assistant Professor at McGill University in Montreal, Canada. He applies implementation science to integrate research into practice, enhancing healthcare outcomes, particularly in infectious disease care and for equity-deserving groups. He his the Co-Lead of the Implementation Science Research Stream of the Canadian Network on Hepatitis C.
Dr. David de Gijsel
Chief Health Officer
Better Life Partners
MOBILE TELE-TREATMENT OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN RURAL NORTHERN NEW ENGLAND (USA): EARLY FINDINGS FROM A RANDOMIZED TRIAL
2:45 PM - 3:00 PMBiography
Dr. de Gijsel is Assistant Professor of Medicine, Section of Infectious Disease and International Health at Dartmouth Medical School and Chief Health Officer for Better Life Partners, Inc., the health care company serving people with addiction that operated the mobile van.
Miss Annabelle Stevens
Phd Student
Unsw/ Kirby Institute
CHOICE OF HCV TESTING MODALITY AMONG PEOPLE AT RISK OF HCV INFECTION: THE SELECT STUDY
3:00 PM - 3:05 PMBiography
Annabelle Stevens is a PhD student at the Kirby Institute, University of NSW. Her PhD is titled 'Evaluation of hepatitis C diagnostic testing strategies to achieve elimination in Australia'. She is passionate about providing equitable health care for vulnerable populations and achieving hepatitis C elimination in NSW.
Dr. Hunter Spencer
Assistant Professor Of Medicine
Oregon Health & Science University
Peer-Assisted Telemedicine for Hepatitis C is more effective in those with unstable housing: Secondary outcomes of a randomized controlled trial.
3:05 PM - 3:10 PMBiography
Dr. Spencer is a translational clinician-scientist focused on achieving health equity by ending the syndemics afflicting people who use drugs (PWUD). He researches telemedicine-based HIV prevention and HCV treatment in rural PWUD. He practices general internal medicine and HIV medicine at Oregon Health & Sciences University in Portland, Oregon.
Ms Alex Wade
Team Leader| Clinical Nurse Consultant - Hepatology Board Member Australasian Hepatology Association (AHA)Mid North Coast Liver Clinics / Drug and Alcohol ServiceCoffs Harbour | Grafton | Kempsey | Port Macquarie
MNC Liver Clinics
AN INNOVATIVE FINANCIAL INCENTIVE MODEL USING REIMBURSEMENT OF GOVERNMENT FINES TO ENHANCE TESTING, LINKAGE TO CARE AND TREATMENT FOR HCV INFECTION AMONG AT-RISK PEOPLE IN NEW SOUTH WALES, AUSTRALIA
3:10 PM - 3:15 PMBiography
Alex Wade is a CNC in Hepatology in NSW, Australia and works across the Public Health Unit and AOD services in her region. She is PI on several HCV related research projects. Alex is the current secretary for the Australasian Hepatology Association and a board member for Frankly Healthcare Association.
Ms Pippa Bray
Coordinator, NSW Point of Care Testing Programs and Research
Hepatitis New South Wales
Ms Rajani Raghu
Scientist
UKHSA
Dr. Bao Vu
Senior Technical Director, HIV/TB/VH
PATH
HEPATITIS C VIRUS SELF-TESTING: AN EFFECTIVE APPROACH TO REACH UNREACHED PEOPLE WHO INJECT DRUGS FOR HCV TESTING AND TREATMENT IN VIETNAM
3:25 PM - 3:30 PMBiography
Dr. Bao Vu is an infectious disease physician, with more than 20 years of experiences working as clinician, researcher and public health professional in HIV, tuberculosis, viral hepatitis,. He currently works for PATH in Vietnam as Senior Technical Director leading HIV, TB, and viral hepatitis programs.
Chairperson
Sigurdur Olafsson
Md
Landspitali University Hospital
Bec Winter
Deputy Head Justice Health
Burnet Institute
